Skip to content

Testing the effectiveness of a web-based intervention to reduce alcohol consumption

Web-based Treatment Trial among Problematic Alcohol Users

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN76859689
Enrollment
520
Registered
2015-09-08
Start date
2015-11-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Harmful or hazardous alcohol use Mental and Behavioural Disorders Harmful or hazardous alcohol use

Interventions

After ensuring that potential participants are eligible for the study (i.e., after a baseline assessment), they will be randomized by a computer program to 1 of 2 parallel groups: 1. Experimental int
and 2. Control condition: waiting list. The web-based self-help intervention (study arm 1) consist of a diary (assesses daily alcohol consumption) and several (currently 8) modules based on the princ

Sponsors

Swiss Foundation for Alcohol Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over 2. AUDIT score = 8 and = 20 (AUDIT = Alcohol Use Disorder Inventory Test) 3. CES-D-20 score < 16 (Center of Epidemiological Studies of Depression) 4. Weekly Internet access

Exclusion criteria

Exclusion criteria: 1. Participation in other psycho-social or pharmacological treatments for the reduction/cessation of alcohol use or the reduction of depression symptoms 2. Use of opioids or stimulants in the last 12 months and/or cannabis use of more than once a week in the previous 30 days 3. Previous treatment for cardiovascular problems 4. Suicidal thoughts or plans in the last 12 months 5. Pregnancy or breast feeding in female participants

Design outcomes

Primary

MeasureTime frame
The number of weekly standard drinks will be assessed with timeline follow-back (TLFB) at baseline, 3 months and 6 months.

Secondary

MeasureTime frame
1. Depressive symptoms assessed with the "Center of Epidemiologic Studies of Depression" (CES-D-20) at baseline, 3 months and 6 months 2. Use of tobacco and illicit drugs assessed with the "Fragebogen Substanzanamnese" questionnaire (FDA) at baseline, 3 months and 6 months 3. Changes in mental health symptoms assessed with the Mental Health Inventory questionnaire (MHI-5) at baseline, 3 months and 6 months 4. Treatment retention measured by using the diary every week over the 6-weeks of intervention 5. Cost-effectiveness-analyses assessed with the EuroQol Quality of Life questionnaire (EQ-5D-3L) at baseline, 3 months and 6 months 6. Cost-utility-analysis and client intervention satisfaction assessed with the Questionnaire on healthcare utilization and productivity losses (TiC-P) at baseline, 3 months and 6 months 7. The "Customer Satisfaction Questionnaire" (CSQ-8) is used as secondary outcome only for participants who have received web-based self-help intervention for 6 weeks (i.e., not used for the control group) measured every week over the 6-weeks of intervention 8. Drinking behaviour is determined using the total score of the short version of the Alcohol Use Disorders Identification Test (AUDIT-C) at baseline, 3 months and 6 months

Countries

Germany, Netherlands, Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026